PubRank

J Curtis Nickel

Author PubWeight™ 95.79‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Demographic and clinical characteristics of men with chronic prostatitis: the national institutes of health chronic prostatitis cohort study. J Urol 2002 3.14
2 Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. Urology 2002 2.94
3 Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med 2004 2.82
4 Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis. JAMA 2011 2.80
5 Contemporary management of the painful bladder: a systematic review. Eur Urol 2011 2.39
6 Dutasteride improves outcomes of benign prostatic hyperplasia when evaluated for prostate cancer risk reduction: secondary analysis of the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial. Urology 2011 2.28
7 Impact of post-ejaculatory pain in men with category III chronic prostatitis/chronic pelvic pain syndrome. J Urol 2004 1.76
8 Impact of medical therapy on transurethral resection of the prostate: two decades of change. BJU Int 2010 1.73
9 Acupuncture ameliorates symptoms in men with chronic prostatitis/chronic pelvic pain syndrome. Urology 2003 1.68
10 Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: results from the REDUCE study. Cancer 2013 1.66
11 α-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome. BJU Int 2012 1.62
12 Effect of pentosan polysulfate therapy on intravesical potassium sensitivity. Urology 2002 1.57
13 An economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia. Can J Urol 2004 1.56
14 Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial. Arch Intern Med 2010 1.55
15 A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis. J Urol 2005 1.54
16 Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial. JAMA 2011 1.46
17 Self-reported spousal support modifies the negative impact of pain on disability in men with chronic prostatitis/chronic pelvic pain syndrome. Urology 2011 1.44
18 Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study. Urology 2003 1.43
19 Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity. Urology 2009 1.39
20 The chronic prostatitis-chronic pelvic pain syndrome can be characterized by prostatic tissue pressure measurements. J Urol 2002 1.39
21 Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT. Urology 2010 1.38
22 Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study. J Urol 2002 1.31
23 Benign prostatic hyperplasia: a progressive disease of aging men. Urology 2003 1.31
24 Dietary patterns and risk of prostate cancer in Ontario, Canada. Int J Cancer 2005 1.26
25 Uncomplicated urinary tract infection in women. Current practice and the effect of antibiotic resistance on empiric treatment. Can Fam Physician 2006 1.22
26 Catastrophizing and pain-contingent rest predict patient adjustment in men with chronic prostatitis/chronic pelvic pain syndrome. J Pain 2006 1.22
27 Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome. Urology 2002 1.21
28 Urogenital pain--time to accept a new approach to phenotyping and, as a consequence, management. Eur Urol 2007 1.19
29 Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome. J Urol 2010 1.17
30 Chronic prostatitis/chronic pelvic pain syndrome and male interstitial cystitis: enigmas and opportunities. Urology 2007 1.10
31 Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasia. J Urol 2004 1.09
32 Adrenocortical hormone abnormalities in men with chronic prostatitis/chronic pelvic pain syndrome. Urology 2008 1.09
33 Diagnosis and management of benign prostatic hyperplasia in primary care. Can Urol Assoc J 2009 1.08
34 A feasibility trial of a cognitive-behavioural symptom management program for chronic pelvic pain for men with refractory chronic prostatitis/chronic pelvic pain syndrome. Can Urol Assoc J 2011 1.04
35 Sexual functioning, catastrophizing, depression, and pain, as predictors of quality of life in women with interstitial cystitis/painful bladder syndrome. Urology 2009 1.04
36 Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia. Clin Trials 2009 0.99
37 Prevalence, symptom impact and predictors of chronic prostatitis-like symptoms in Canadian males aged 16-19 years. BJU Int 2008 0.99
38 Cost-effectiveness of dutasteride-tamsulosin combination therapy for the treatment of symptomatic benign prostatic hyperplasia: A Canadian model based on the CombAT trial. Can Urol Assoc J 2013 0.97
39 Classification and treatment of men with chronic prostatitis/chronic pelvic pain syndrome using the UPOINT system. World J Urol 2013 0.97
40 Comparison of clinical trials with finasteride and dutasteride. Rev Urol 2004 0.97
41 Overview summary statement. Diagnosis and management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Urology 2002 0.96
42 A 2-year follow-up of quality of life, pain, and psychosocial factors in patients with chronic prostatitis/chronic pelvic pain syndrome and their spouses. World J Urol 2013 0.95
43 Mapping of pain phenotypes in female patients with bladder pain syndrome/interstitial cystitis and controls. Eur Urol 2012 0.92
44 Treatment of phimosis with topical steroids in 194 children. J Urol 2003 0.92
45 National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome. Eur Urol 2012 0.89
46 Sexual and relationship functioning in men with chronic prostatitis/chronic pelvic pain syndrome and their partners. Arch Sex Behav 2006 0.88
47 Interstitial cystitis/bladder pain syndrome and nonbladder syndromes: facts and hypotheses. Urology 2011 0.87
48 Plasma organochlorine levels and prostate cancer risk. J Expo Sci Environ Epidemiol 2009 0.87
49 Benign prostatic hyperplasia: does prostate size matter? Rev Urol 2003 0.87
50 Practical management of recurrent urinary tract infections in premenopausal women. Rev Urol 2005 0.85
51 Prostatitis and prostate cancer: implications for prostate cancer screening. Urology 2004 0.84
52 Spousal support decreases the negative impact of pain on mental quality of life in women with interstitial cystitis/painful bladder syndrome. BJU Int 2010 0.83
53 Changing paradigms for chronic pelvic pain: a report from the chronic pelvic pain/chronic prostatitis scientific workshop, october 19-21, 2005, Baltimore, MD. Rev Urol 2006 0.83
54 Followup of patients with interstitial cystitis responsive to treatment with intravesical bacillus Calmette-Guerin or placebo. J Urol 2007 0.83
55 Efficacy of intravesical chondroitin sulphate in treatment of interstitial cystitis/bladder pain syndrome (IC/BPS): Individual patient data (IPD) meta-analytical approach. Can Urol Assoc J 2013 0.82
56 Did patients with interstitial cystitis who failed to respond to initial treatment with bacillus Calmette-Guerin or placebo in a randomized clinical trial benefit from a second course of open label bacillus Calmette-Guerin? J Urol 2007 0.81
57 Understanding chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). World J Urol 2013 0.81
58 Interstitial cystitis: characterization and management of an enigmatic urologic syndrome. Rev Urol 2002 0.80
59 Canadian Consensus Conference: The FDA decision on the use of 5ARIs. Can Urol Assoc J 2012 0.80
60 Diagnosis of interstitial cystitis June 2007. Can Urol Assoc J 2009 0.80
61 Association between response to pentosan polysulfate sodium therapy for interstitial cystitis and patient questionnaire-based treatment satisfaction. Curr Med Res Opin 2008 0.79
62 Interstitial cystitis--an elusive clinical target? J Urol 2003 0.79
63 Early termination of a trial of mycophenolate mofetil for treatment of interstitial cystitis/painful bladder syndrome: lessons learned. J Urol 2011 0.79
64 Chronic prostatitis-like symptoms in African males aged 16-19 years. Can J Urol 2012 0.79
65 A multi-site study confirms abnormal glycosylation in the Tamm-Horsfall protein of patients with interstitial cystitis. J Urol 2011 0.79
66 Management of urinary tract infections in children: simplifying the controversies? Rev Urol 2003 0.78
67 Disability in women suffering from interstitial cystitis/bladder pain syndrome. BJU Int 2012 0.77
68 Quercetin for chronic prostatitis/chronic pelvic pain syndrome. Urol Clin North Am 2011 0.77
69 Early symptom improvement of benign prostatic hyperplasia (BPH) treated with once daily alfuzosin. Can J Urol 2005 0.76
70 Best of the 2009 AUA Annual Meeting: Highlights from the 2009 Annual Meeting of the American Urological Association, April 25-30, 2009, Chicago, IL. Rev Urol 2009 0.75
71 Re: a new high frequency electrostimulation device to treat chronic prostatitis. J Urol 2004 0.75
72 Best of the 2013 AUA Annual Meeting: Highlights From the 2013 American Urological Association Meeting, May 4-8, 2013, San Diego, CA. Rev Urol 2013 0.75
73 Interstitial cystitis: the paradigm shifts: international consultations on interstitial cystitis. Rev Urol 2004 0.75
74 Recurrent uncomplicated urinary tract infections: can young women diagnose and treat themselves? Rev Urol 2002 0.75
75 Pseudomonas aeruginosa bacteremia and prostatitis in a patient with cystic fibrosis. Can Urol Assoc J 2013 0.75
76 Disappointing news for urologists managing interstitial cystitis patients. Rev Urol 2006 0.75
77 Immunological based therapies for urinary tract infection: the future is almost here! Rev Urol 2002 0.75
78 Chronic epididymitis: a practical approach to understanding and managing a difficult urologic enigma. Rev Urol 2003 0.75
79 Best of the 2008 AUA Annual Meeting: Highlights from the 2008 Annual Meeting of the American Urological Association, May 17-22, 2008, Orlando, FL. Rev Urol 2008 0.75
80 Prostatitis/Chronic pelvic pain syndrome. Rev Urol 2002 0.75
81 Best of the AUA Annual Meeting: Highlights From the 2011 American Urological Association Meeting, May 14-19, 2011, Washington, DC. Rev Urol 2011 0.75
82 alpha-Blockers for Treatment of the Prostatitis Syndromes. Rev Urol 2005 0.75
83 Editorial comment. Urology 2012 0.75
84 Antibiotics and alpha-Blockers for Chronic Prostatitis: Evidence From Recent Randomized Placebo-Controlled Studies. Rev Urol 2005 0.75
85 Clinical characterization of the prostatitis patient in Italy: a prospective urology outpatient study. World J Urol 2004 0.75
86 Lower urinary tract symptoms in men: A case-based discussion. Can Urol Assoc J 2012 0.75
87 Benign prostatic hyperplasia: from A - Z. Can J Urol 2003 0.75
88 Benign prostatic hyperplasia: case scenarios. Rev Urol 2003 0.75
89 Prostatitis and chronic pelvic pain syndrome in men. Med Clin North Am 2010 0.75
90 Acupuncture for chronic prostatitis/chronic pelvic pain syndrome. Curr Urol Rep 2004 0.75
91 Hypersensitivity reaction associated with intravesical bacillus Calmette-Guerin for interstitial cystitis. J Urol 2004 0.75
92 Best of the SIU Meeting on Prostatic Disease: Highlights from the Société Internationale d'Urologie Meeting on Prostatic Disease: Recent Advances and New Technologies, September 29-October 1, 2005, Bariloche, Patagonia, Argentina. Rev Urol 2005 0.75
93 The challenges of lower urinary tract symptoms in men. Can Urol Assoc J 2012 0.75